Navigation Links
Amgen And ShanghaiTech University Announce Plans For Amgen China R&D Center To Open On ShanghaiTech Campus
Date:9/24/2013

news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2012, and in any subsequent periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign), and difficulties or delays in manufacturing our products. In addition, sales of our products are affected by reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. If we fail to meet the complian
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
2. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
3. Amgen Announces 2012 First Quarter Dividend
4. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
5. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
6. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
7. Amgen to Acquire Micromet
8. Amgen to Present at the Leerink Swann Global Healthcare Conference
9. Amgen Announces 2012 Third Quarter Dividend
10. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
11. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014 Minerva Neurosciences (NASDAQ: ... of new therapies to treat neuropsychiatric diseases and disorders, ... been appointed vice president of finance and chief accounting ... is a senior executive with more than 20 years ... and life science companies. His background includes the management ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... registry platform, announced that three PatientCrossroads-based patient ... the Phelan-McDermid Syndrome International Registry; and the ... been awarded contracts by the Patient-Centered Outcomes ... creation of a new health data network ...
(Date:7/13/2014)... (Brown University) -- The discovery 30 years ago of ... explosion of nanotechnology research. Now, there appears to be ... Brown University, Shanxi University and Tsinghua University in China ... forms a hollow molecular cage similar to a carbon ... cage structurepreviously only a matter of speculationdoes indeed exist. ...
(Date:7/13/2014)... 2014 Deep Research Report on Global ... in-depth study on the current state of the Nano ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
Breaking Biology Technology:Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3
... April 28 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ... novel zinc finger DNA-binding proteins (ZFPs) for therapeutic ... Thomas G.,Wiggans to the company,s Board of Directors., ... Executive Officer of,Connetics Corporation, a biotechnology company, from ...
... ... product, ... Lucas has joined the Company as vice president,of sales and marketing. ... strategy, building the sales force, and leading the,commercial introduction of the ...
... CHINA, April 28 Simcere,Pharmaceutical Group (NYSE: ... generic pharmaceuticals and manufacturer of the patented,anti-cancer biotech ... has been,informed that one of its existing shareholders, ... beneficially owned by 15,individuals, including certain senior management ...
Cached Biology Technology:Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 4AssureRx Adds VP of Sales and Marketing 2Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 2Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 3
(Date:7/14/2014)... that could overcome a major cost barrier to ... could replace expensive and environmentally harmful fossil fuels. ... that performs almost as well as cost-prohibitive platinum ... to split water molecules into hydrogen and oxygen. ... than less-expensive catalysts investigated to-date. , "Hydrogen has ...
(Date:7/14/2014)... to reliably and safely make in the laboratory all of ... key step closer to reality. , Writing today in the ... of Wisconsin-Madison stem cell researcher Igor Slukvin reports the discovery ... and turning them into both red and the array of ... is important because it identifies how nature itself makes blood ...
(Date:7/13/2014)... in women suggests that experiencing one or more stressful ... can slow the body,s metabolism, potentially contributing to weight ... day,s stressors before giving them a meal consisting of ... then measured their metabolic rate how long it ... and took measures of blood sugar, triglycerides, insulin and ...
Breaking Biology News(10 mins):Rutgers chemists develop technology to produce clean-burning hydrogen fuel 2Wisconsin scientists find genetic recipe to turn stem cells to blood 2Wisconsin scientists find genetic recipe to turn stem cells to blood 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4
... Peering deep within the cells of fruit flies, developmental ... University in Philadelphia may have discovered a new way ... If they're right, and the same processes are at ... eventually have implications for improving the understanding of a ...
... change will have major effects on coral reefs ?and has ... from the ARC Centre of Excellence for Coral Reef Studies ... engineering model to predict how much damage a reef is ... sea. , In a paper in the international ...
... unique Mayo Clinic collaboration has revived the healing wisdom ... extract described in a 17th century Dutch herbal text ... from the Atun tree effectively control bacteria that can ... circa 1650. He documented his traditional healing methods in ...
Cached Biology News:Jefferson researchers uncover new way nature turns genes on and off 2Stormy days ahead for coral reefs 2Stormy days ahead for coral reefs 3Mayo Clinic collaboration mining of ancient herbal text leads to potential new anti-bacterial drug 2
Request Info...
Shake 'n' Stack oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual)...
... Polymerase I from E. coli ... The enzyme also contains both ... 5'?3' exonuclease activity enables the ... gaps in the DNA as ...
... Stem Cell Expansion Kit - Monolayer Plus is ... NSC expansion as a monolayer in a serum-free ... Plus Media Supplement, which has been optimized for ... al . (1996) Genes & Development 10 ...
Biology Products: